ArticleIranian journal of public health2021
Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients.
Abdorreza Naser MoghadasiPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.